Other outcome measures sought, such as number of racemic epinephrine treatments or croup scores, were not reported in these studies. In the two pediatric prophylaxis trials with 216 total patients ...
The company’s lead drug candidate utilizing WaferiX is Wafermine, the world’s first patented sublingual racemic ketamine wafer for the treatment of acute moderate to severe pain and major ...